Institutional investors purchased a net $15.3 million shares of MNKD during the quarter ended June 2014. This may signal that the smart money is gaining interest in this company as the 22.06% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
FIDELITY MANAGEMENT & RESEARCH C... Bought 9.2 Million shares of Mannkind Corp
BLACKROCK FUND ADVISORS Bought 1.8 Million shares of Mannkind Corp
RENAISSANCE TECHNOLOGIES LLC Bought 1.8 Million shares of Mannkind Corp